Aneurysmal Subarachnoid Hemorrhage during the Shutdown for COVID-19.
COVID-19
Poisson regression
aneurysm
aneurysmal subarachnoid hemorrhage
inflammation
neurosurgery
stroke
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
02 May 2022
02 May 2022
Historique:
received:
30
03
2022
revised:
25
04
2022
accepted:
29
04
2022
entrez:
14
5
2022
pubmed:
15
5
2022
medline:
15
5
2022
Statut:
epublish
Résumé
The aim was to evaluate hospitalization rates for aneurysmal subarachnoid hemorrhage (SAH) within an interdisciplinary multicenter neurovascular network (NVN) during the shutdown for the COVID-19 pandemic along with its modifiable risk factors. In this multicenter study, admission rates for SAH were compared for the period of the shutdown for the COVID-19 pandemic in Germany (calendar weeks (cw) 12 to 16, 2020), the periods before (cw 6-11) and after the shutdown (cw 17-21 and 22-26, 2020), as well as with the corresponding cw in the years 2015-2019. Data on all-cause and pre-hospital mortality within the area of the NVN were retrieved from the Department of Health, and the responsible emergency medical services. Data on known triggers for systemic inflammation, e.g., respiratory viruses and air pollution, were analyzed. Hospitalizations for SAH decreased during the shutdown period to one-tenth within the multicenter NVN. There was a substantial decrease in acute respiratory illness rates, and of air pollution during the shutdown period. The implementation of public health measures, e.g., contact restrictions and increased personal hygiene during the shutdown, might positively influence modifiable risk factors, e.g., systemic inflammation, leading to a decrease in the incidence of SAH.
Identifiants
pubmed: 35566681
pii: jcm11092555
doi: 10.3390/jcm11092555
pmc: PMC9104869
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Neurosurg. 2016 Sep;125(3):737-45
pubmed: 26824376
Stroke. 2020 Aug;51(8):2395-2403
pubmed: 32586226
Lancet Planet Health. 2020 Jun;4(6):e210-e212
pubmed: 32411944
Nicotine Tob Res. 2020 Aug 24;22(9):1662-1663
pubmed: 32343816
J Crit Care. 2020 Dec;60:45-49
pubmed: 32739759
N Engl J Med. 2004 Dec 16;351(25):2611-8
pubmed: 15602021
Neuroepidemiology. 2017;48(3-4):103-110
pubmed: 28628919
Stroke. 2007 Apr;38(4):1216-21
pubmed: 17322078
CNS Neurosci Ther. 2012 Jun;18(6):501-8
pubmed: 22672304
Stroke. 2013 Dec;44(12):3607-12
pubmed: 24193807
Circulation. 2003 Feb 11;107(5):762-8
pubmed: 12578882
Stroke. 2013 Dec;44(12):3613-22
pubmed: 24130141
Toxicol Pathol. 2002 May-Jun;30(3):373-89
pubmed: 12051555
Lancet. 2017 May 13;389(10082):1907-1918
pubmed: 28408086
Heart. 2016 Dec 15;102(24):1953-1956
pubmed: 27686519
J Immunol Res. 2017;2017:8160589
pubmed: 29445758
J Neurol. 2019 Jun;266(6):1351-1357
pubmed: 30834980
BMJ. 2015 Mar 24;350:h1295
pubmed: 25810496
Rev Environ Health. 2012;27(2-3):133-49
pubmed: 23023922
Brain. 2001 Feb;124(Pt 2):249-78
pubmed: 11157554
Heart. 2015 Nov;101(21):1738-47
pubmed: 26310262
J Neurol Neurosurg Psychiatry. 2007 Dec;78(12):1365-72
pubmed: 17470467
Sci Total Environ. 2020 Nov 1;741:140426
pubmed: 32593893
Stroke. 2013 Nov;44(11):3027-31
pubmed: 24003049
Lancet. 2015 Oct 31;386(10005):1739-46
pubmed: 26298822
Compr Physiol. 2017 Sep 12;7(4):1479-1495
pubmed: 28915333
Cerebrovasc Dis. 2000 Sep-Oct;10(5):352-8
pubmed: 10971020
Ann Clin Transl Neurol. 2018 Mar 14;5(4):456-463
pubmed: 29687022
Neuroepidemiology. 2014;42(2):90-7
pubmed: 24334973
Nat Rev Neurol. 2010 Dec;6(12):681-94
pubmed: 21060340
Dtsch Arztebl Int. 2020 Aug 17;117(33-34):545-552
pubmed: 32865489
Circulation. 2010 Jun 1;121(21):2331-78
pubmed: 20458016
BMC Neurol. 2016 May 04;16:59
pubmed: 27146603
Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1793-1800
pubmed: 28751572
J Cereb Blood Flow Metab. 2019 Jun;39(6):959-988
pubmed: 30961425
Euro Surveill. 2014 Jan 30;19(4):
pubmed: 24507468
Stroke. 1999 Nov;30(11):2268-71
pubmed: 10548655
Eur Heart J. 2020 Jun 7;41(22):2083-2088
pubmed: 32412631